Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKinsey
Harvard Business School
Baxter
Colorcon
Johnson and Johnson

Last Updated: December 14, 2019

DrugPatentWatch Database Preview

Litigation Details for Bayer Healthcare LLC v. Apotex Inc. (D. Del. 2016)

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Bayer Healthcare LLC v. Apotex Inc. (D. Del. 2016)

Docket   Start Trial Date Filed 2016-12-16
Court District Court, D. Delaware Date Terminated
Cause 35:271 Patent Infringement Assigned To Leonard Philip Stark
Jury Demand None Referred To
Parties APOTEX CORP.; APOTEX INC.; BAYER HEALTHCARE LLC; BAYER HEALTHCARE PHARMACEUTICALS INC.; TEVA PHARMACEUTICAL INDUSTRIES, LTD.; TEVA PHARMACEUTICALS USA, INC.
Patents 7,351,834; 8,637,553; 8,680,124; 9,458,107; 9,957,232
Attorneys Adam L. Perlman; Alexandra J. Olson; Anthony David Raucci; Ben V. Picozzi; Bruce R. Genderson; Derek James Fahnestock; Dov P. Grossman; Jack B. Blumenfeld; Jenell C. Bilek; Jessica B. Rydstrom; Karen Elizabeth Keller; Kenneth Laurence Dorsney; Mark D. Schuman; Nathan D. Louwagie; Philip Y. Kouyoumdjian; Samuel T. Lockner; Seth R. Bowers; Shelleaha L. Jonas; Todd S. Werner; Xiao Wang
Firms Morris, Nichols, Arsht & Tunnell; Shaw Keller LLP
Link to Docket External link to docket
Small Molecule Drugs cited in Bayer Healthcare LLC v. Apotex Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial and   Start Trial .

Details for Bayer Healthcare LLC v. Apotex Inc. (D. Del. 2016)

Date Filed Document No. Description Snippet Link To Document
2018-12-28 106 (l) as to the U.S. Patent No. 8,637,553 (the '553 patent) and U.S. Patent No. 9,458,107 ("…Procedure 26(a)(l) as to U.S. Patent No. 9,957,232 ("the ' 232 patent") within ten (10) …; 553 and ' l 07 patents has already passed. As to the '232 patent, all motions to join other…#39;553 and ' 107 patents has already concluded. As for the '232 patent, the parties agree that…#39; 553 and ' 107 patents has already passed. As for the '232 patent, absent agreement among External link to document
2019-01-07 107 a)(1) Initial Disclosures regarding U.S. Patent No. 9,957,232 filed by Apotex Corp., Apotex Inc..(Dorsney…16 December 2016 1:16-cv-01221 830 Patent None District Court, D. Delaware External link to document
2019-01-14 108 Pharaceuticals Inc.'s Initial Disclosures as to U.S. Patent No. 9,957,232 filed by Bayer HealthCare Pharmaceuticals…16 December 2016 1:16-cv-01221 830 Patent None District Court, D. Delaware External link to document
2019-01-28 109 Interrogatories (Nos. 1-4) to Apotex Regarding U.S. Patent No. 9,957,232 and (2) Plaintiffs Bayer HealthCare LLC …Pharmaceuticals Inc.'s Initial Disclosures as to U.S. Patent No. 9,957,232 pursuant to Paragraph 4 of the District …16 December 2016 1:16-cv-01221 830 Patent None District Court, D. Delaware External link to document
2016-12-16 3 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,351,834 B1; 8,637,553 B2; 8,680,124…16 December 2016 1:16-cv-01221 830 Patent None District Court, D. Delaware External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Express Scripts
Medtronic
Moodys
Baxter
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.